HCV agreement for Merck and BMS
April 23, 2013Research and Development, Sales and Marketing BMS, HCV, Merck
Merck & Co and Bristol-Myers Squibb have signed a non-exclusive agreement to conduct a Phase II trial looking at a …
AstraZeneca signs $200m nanomedicine deal
April 23, 2013Research and Development, Sales and Marketing AstraZeneca, bind therapeutics, nanomedicine
AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …
Orexigen’s chief executive elected to PhRMA Board
April 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PhRMA, orexigen
Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …
DSM plans July opening for Australian biopharma facility
April 23, 2013Manufacturing and Production CMO, DSM
Contract manufacturing organisation DSM Pharmaceutical Products is planning to officially open a new biopharma plant in Australia in July as …
J&J sees OTC recovery in Q1
April 23, 2013Manufacturing and Production J&J, JJ, manufacturing issues, recall
Johnson & Johnson is moving steadily closer to a sustained recovery in its McNeil Consumer Healthcare division as the manufacturing …
German regulator assesses more drugs
April 22, 2013Sales and Marketing AMNOG, Bayer, Germany, Pradaxa, Xarelto
A new raft of drugs which will be subject to potentially stringent cost/benefit analysis in Germany has been announced. The …
‘No consensus’ on transparency
April 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency
An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …
New appointments to advise ministers on proposed NHS changes
April 22, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, granger, reforms
The Department of Health has announced that five new members will join the Independent Reconfiguration Panel (IRP) from May. The …
Sanofi reinforces presence in Morocco
April 19, 2013Manufacturing and Production Morocco, Sanofi, emerging markets, logistics
Sanofi has opened a new logistics hub in Morocco to help it increase and accelerate distribution of its medicines throughout …
Jail for man in data trial
April 19, 2013Sales and Marketing MHRA, Scientist
A British scientist has become the first person to be jailed under the Good Laboratory Practice (GLP) Regulations 1999 for …
Merck opens $120m China factory
April 19, 2013Manufacturing and Production, Sales and Marketing China, Merck
Merck is to open a new manufacturing facility in Hangzhou, two decades after the company built its first plant in …
Takeda rapped over quality control failure in Japan
April 19, 2013Manufacturing and Production GMP, OPMA, Takeda
Takeda Pharmaceutical has been penalised by its local trade organisation over the quality failings that led to the recall of …
Sanofi earmarks $75m for Vietnamese plant
April 19, 2013Manufacturing and Production Sanofi, vietnam
Sanofi has broken ground on a new manufacturing facility in Ho Chi Minh City, Vietnam, as part of its push …
GSK faces £2.6 billion fine
April 19, 2013Sales and Marketing GSK, Seroxat, paroxetine
GlaxoSmithKline could be fined £2.6 billion after the Office of Fair Trading (OFT) alleged it paid generics firms to slow …
Digital ad monitoring for UK pharma market launched
April 19, 2013Medical Communications ebiquity
Ebiquity has launched a new service to monitor and benchmark advertising spend and creative for the UK healthcare market. The …
Venaxis appoints former Pfizer executive to Board of directors
April 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, venaxis, williams
Diganostic firm Venaxis has appointed SomaLogic’s chief medical officer Stephen Williams to the company’s Board of directors.
£3.5 million for health charities
April 18, 2013Sales and Marketing NHS, UK
A raft of voluntary of charities and community groups are to share £3.5 million in the next financial year as …
Covance opens expanded Singapore lab
April 18, 2013Research and Development Covance
Covance has expanded its central laboratory facility in Singapore to meet growing demand for drug development services in the Asia-Pacific …
Lilly increases Alzheimer’s R&D
April 18, 2013Research and Development, Sales and Marketing Alzheimer's, lilly
Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …
Oxford Cancer Biomarkers signs discovery deal with AstraZeneca
April 18, 2013Research and Development AstraZeneca, Oxford Cancer Biomarkers
AstraZeneca has signed a new alliance with a UK firm in the field of biomarker discovery.Oxford Cancer Biomarkers is developing …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
